Cargando…
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
BACKGROUND: People who inject drugs are at high risk for hepatitis B, hepatitis C and HIV. HTLV was reported by neighboring countries to be prevalent in this population, but the situation for Germany is unclear. To generate seroprevalence and related behavioural data and to enhance prevention effort...
Autores principales: | Zimmermann, Ruth, Marcus, Ulrich, Schäffer, Dirk, Leicht, Astrid, Wenz, Benjamin, Nielsen, Stine, Santos-Hövener, Claudia, Stefan Ross, R, Stambouli, Oumaima, Ratsch, Boris-Alexander, Bannert, Norbert, Bock, Claus-Thomas, Kücherer, Claudia, Hamouda, Osamah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247126/ https://www.ncbi.nlm.nih.gov/pubmed/25124485 http://dx.doi.org/10.1186/1471-2458-14-845 |
Ejemplares similares
-
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)
por: Wenz, Benjamin, et al.
Publicado: (2016) -
Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017) -
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
por: Nielsen, Stine, et al.
Publicado: (2016) -
Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls
por: Santos-Hövener, Claudia, et al.
Publicado: (2014) -
No significant HTLV seroprevalence in German people who inject drugs
por: Hohn, Oliver, et al.
Publicado: (2017)